What is Opko Health Inc Annual Revenue?

Opko Health Inc Annual Revenue fell 17.41%, in the last year to $713.14 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

What is Opko Health Inc Annual Net Profit?

Opko Health Inc Annual Net Profit rose 71.82% in the last year to $53.22 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

What is Opko Health Inc Price to Earning Ratio?

Opko Health Inc Price to Earning Ratio is -21.16, which is negative.

What is Opko Health Inc Stock Price?

Opko Health Inc Stock Price rose 15.45% and outperformed its sector by 11.27% in the past year.

What is Opko Health Inc Quarterly Revenue?

Opko Health Inc Quarterly Revenue rose 0.95% YoY to $183.64 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

What is Opko Health Inc Quarterly Net profit?

Opko Health Inc Quarterly Net profit rose 121.1% YoY to $14.03 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

What is Opko Health Inc Debt to Equity Ratio?

Opko Health Inc Debt to Equity Ratio of 0.37 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Opko Health Inc Return on Equity(ROE)?

Opko Health Inc Return on Equity(ROE) for the last financial year was -3.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Opko Health Inc Mutual Fund Holding?

Opko Health Inc Mutual Fund Holding decreased by 0.35% in the last quarter to 15.95.

What is Opko Health Inc Promoter Share Holding?

Opko Health Inc Promoter Share Holding stayed the same in the most recent quarter at 6.18%.

What is Opko Health Inc Interest Coverage Ratio?

Opko Health Inc Interest Coverage Ratio is 0.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Opko Health Inc Institutional Holding?

Opko Health Inc Institutional Holding increased by 0.01% in the last quarter to 29.74.

How is the Opko Health Inc today?

The Opko Health Inc today is trading in the down by 0.00% at 1.42.

How has Opko Health Inc performed historically?

The Opko Health Inc is currently trading down 0.00% on an intraday basis in the past week the index fell 0.00%. The index has been down -3.40% in the past quarter and rose 15.45% in the past year. You can view this in the overview section.

Opko Health Inc XNAS: OPK

Opko Health Inc Live Share Price Today, Share Analysis and Chart

Name: Opko Health Inc: Is Infosys Ltd. worth buying?
Item: Opko Health Inc
Rating: 1.481986125
Author: Trendlyne DVM scores

Momentum Trap

Download real time

1.42 0.00 (0.00%)

30.39% Fall from 52W High

2.2M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Opko Health Inc is on 23 Apr 2025 for the purpose of OPKO Health Inc Annual General Meeting for 2025 See details

Opko Health Inc Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	1,126
PE TTM Negative PE TTM Unavailable in chosen country	-21.2
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.3
Price to Book Below industry Median Unavailable in chosen country	0.7
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	29.7
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	1
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-17.4
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	121.1
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	71.8
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-18
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-38.4
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	4.5
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-3.9
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-2.5

All financials are in USD Million and price data in USD

Low Financial Strength

27.8 / 100

Expensive Valuation

18.3 / 100

Technically Neutral

44.7 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 181%

6 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Opko Health Inc Stock Price Analysis

Month Price Range -22.0% 1 Month return Unavailable in chosen country	1.4 (LTP) 1.31.8 LowHigh
52 Week Price Range 15.4% 1 Year return Unavailable in chosen country	1.4 (LTP) 1.22 LowHigh

View full Share Price History

Opko Health Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Opko Health Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.1

Avg. Estimate

-0.3

Low Estimate

-0.6

High Estimate

-0.2

Current EPS

Avg. Estimate

Miss

EPS is expected to reduce by 300.0% in FY25

Consensus Recommendation

6 ANALYST Recommendations

BUY

The consensus recommendation from 6 analysts for Opko Health Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Opko Health Inc Stock Analysis

Opko Health Inc stock analysis with key metrics, changes, and trends.

Opko Health Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$713.14 M	17.41%	negative	Annual Revenue fell 17.41%, in the last year to $713.14 M. Its sector's average revenue growth for the last fiscal year was 8.12%.
Annual Net Profit	$53.22 M	71.82%	positive	Annual Net Profit rose 71.82% in the last year to $53.22 M. Its sector's average net profit growth for the last fiscal year was 3.53%.
Price to Earning Ratio	-21.16	-	negative	Price to Earning Ratio is -21.16, which is negative.
Stock Price	$1.42	15.45%	positive	Stock Price rose 15.45% and outperformed its sector by 11.27% in the past year.
Quarterly Revenue	$183.64 M	0.95%	positive	Quarterly Revenue rose 0.95% YoY to $183.64 M. Its sector's average revenue growth YoY for the quarter was 9.6%.
Quarterly Net profit	$14.03 M	121.1%	positive	Quarterly Net profit rose 121.1% YoY to $14.03 M. Its sector's average net profit growth YoY for the quarter was 36.99%.
Debt to Equity Ratio	0.37	-	positive	Debt to Equity Ratio of 0.37 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-3.86 %	-3.86%	negative	Return on Equity(ROE) for the last financial year was -3.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	15.95 %	-0.35%	negative	Mutual Fund Holding decreased by 0.35% in the last quarter to 15.95.
Promoter Share Holding	6.18 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 6.18%.
Interest Coverage Ratio	0.78	-	negative	Interest Coverage Ratio is 0.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	29.74 %	0.01%	positive	Institutional Holding increased by 0.01% in the last quarter to 29.74.

VIEW LESS

Loading data..

Opko Health Inc - Company Profile

What does Opko Health Inc do?

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

2024

Gross Remuneration

Year

Opko Health Inc Live Share Price Today, Share Analysis and Chart

30.39% Fall from 52W High

Opko Health Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Opko Health Inc Stock Price Analysis

Month Price Range

52 Week Price Range

Opko Health Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Opko Health Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to reduce by 300.0% in FY25

Consensus Recommendation

The consensus recommendation from 6 analysts for Opko Health Inc is BUY

Opko Health Inc Stock Analysis

Opko Health Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 17.41%, in the last year to $713.14 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

Annual Net Profit rose 71.82% in the last year to $53.22 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio is -21.16, which is negative.

Stock Price rose 15.45% and outperformed its sector by 11.27% in the past year.

Quarterly Revenue rose 0.95% YoY to $183.64 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

Quarterly Net profit rose 121.1% YoY to $14.03 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

Debt to Equity Ratio of 0.37 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -3.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.35% in the last quarter to 15.95.

Promoter Share Holding stayed the same in the most recent quarter at 6.18%.

Interest Coverage Ratio is 0.78, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 0.01% in the last quarter to 29.74.

Opko Health Inc - Company Profile

What does Opko Health Inc do?

Opko Health Inc Management structure

Dr. Phillip Frost, M.D.

Chairman of the Board and Chief Executive Officer

Dr. Jane H. Hsiao, M.B.A.,PhD

Vice Chairman of the Board and Chief Technical Officer

Dr. Elias A. Zerhouni, M.D.

President and Vice Chairman of the Board

Mr. Steven D. Rubin

Director and Executive Vice President, Administration

Mr. Adam E. Logal

Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer

Dr. Gary J. Nabel, M.D.,PhD

Chief Innovation Officer and Director

Opko Health Inc Board of directors

Mr. Richard C. Pfenniger, Jr

Lead Independent Director

Dr. Richard M. Krasno, PhD